Mydocs Oral Tablet, Extended Release 600-20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

MyDocs: Oral tablet, extended release (600-20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_1090.JPG
Prolex D 600mg-20mg ER Tab
Blansett Pharmacal Co Inc
Pill Identification: PROLEX- D 
Drug Image file DrugItem_7511.JPG
GFN 600/PE 20 ER Tab
Cypress Pharmaceutical Inc
Pill Identification: CYP 269 

What is this Medicine?

GUAIFENESIN; PHENYLEPHRINE (gwye FEN e sin; fen il EF rin) is a decongestant, expectorant combination. It is used to provide relief from cough and congestion. This medicine will not treat an infection.

Similar Brand Name Drugs : Aldex G: Oral tablet, extended release (835-25mg)  |  Liquibid D: Oral tablet, extended release (600-40mg)  |  Duratuss GP: Oral tablet, extended release (1200-25mg)  |  Duraphen: Oral tablet, extended release (1000-30mg)  |  Duratuss GP: Oral tablet, extended release (1200-120mg)  |  J-Max: Oral tablet, extended release (1200-35mg)  |  Extendryl G: Oral tablet, extended release (1000-30mg)  |  Duratuss: Oral tablet, extended release (900-25mg)  |  Liquibid D: Oral tablet, extended release (1200-40mg)  |  Liquibid PD: Oral tablet, extended release (275-25mg)  |  Xpect-PE: Oral tablet, extended release (1200-25mg)
Similar Generic Drugs : Expectorant with Decongestants: Oral tablet, extended release (650-23.75mg)  |  Expectorant with Decongestants: Oral tablet, extended release (1000-30mg)  |  Expectorant with Decongestants: Oral tablet, extended release (1200-25mg)  |  Expectorant with Decongestants: Oral tablet, extended release (900-25mg)  |  Expectorant with Decongestants: Oral tablet, extended release (275-25mg)  |  Expectorant with Decongestants: Oral tablet, extended release (600-40mg)  |  Expectorant with Decongestants: Oral tablet, extended release (1200-40mg)  |  Expectorant with Decongestants: Oral tablet, extended release (900-30mg)  |  Expectorant with Decongestants: Oral tablet, extended release (835-25mg)  |  Expectorant with Decongestants: Oral tablet, extended release (600-20mg)  |  Expectorant with Decongestants: Oral tablet, extended release (600-25mg)  |  Expectorant with Decongestants: Oral tablet, extended release (600-10mg)
In-Depth Information

MyDocs 600mg-20mg Extended-Release Tablet

NDC: 233590001
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Cough, Common Cold, Eustachian Tube Congestion, Nasal Congestion

Storage Information
Store at room temperature (between 59 to 86 degrees F)
MyDocs 600mg-20mg Extended-Release Tablet
Daily Life Interactions for MyDocs 600mg-20mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and MyDocs 600mg-20mg Extended-Release Tablet(Phenylephrine Hydrochloride)
Caffeine-containing Foods/Beverages and Phenylephrine(Phenylephrine Hydrochloride)
Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Phenylephrine. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Phenylephrine may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with MyDocs

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5